Browse > Article

A Study of Antibody Conversion Rate During a Mycoplasma pneumoniae Epidemic Period(the Second Half of 2003)  

Kim, Do Kyun (Department of Pediatrics, Seoul National University College of Medicine)
Yu, Jinho (Department of Pediatrics, Seoul National University College of Medicine)
Yoo, Young (Department of Pediatrics, Seoul National University College of Medicine)
Koh, Young Yull (Department of Pediatrics, Seoul National University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.5, 2005 , pp. 500-505 More about this Journal
Abstract
Purpose : This study was designed to estimate the prevalence of Mycoplasma pneumoniae infection during an epidemic period by means of examining the antibody conversion rate and to investigate the association of the antibody conversion with age, initial antibody titer, and atopy. Methods : We chose 191 children whose antibody titer to M. pneumoniae was negative, 1 : 40, or 1 : 80 during the first half of 2003. After the second half of 2003 when the M. pneumoniae epidemic occurred, follow-up collection of sera was performed during the first half of 2004. M. pneumoniae antibody titer was measured by Serodia-Myco II particle agglutination test. Results : Of 191 children, antibody conversion was detected in 83 children(43.5 percent). No significant difference was found between the conversion and non-conversion group with respect to age, sex and atopy. Dividing the subjects into four groups by age, results on the antibody conversion rate revealed no significant differences between the groups. Assessed by initial antibody titer, a diminished trend of conversion rate was observed in children with 1 : 80 titer but the difference was not significant. There was no significant difference in the antibody conversion rate between atopic and non-atopic children. Conclusion : Based on the antibody conversion rate in this study, the prevalence of M. pneumoniae infection during an epidemic period was estimated to be 43.5 percent. This high infection rate suggests that during an epidemic, we should bear in mind M. pneumoniae as an important etiologic agent for respiratory infection in children.
Keywords
Mycoplasma pneumoniae; Antibody conversion rate; Epidemic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Clyde WA Jr. Clinical overview of typical Mycoplasma pneumoniae infection. Clin Infect Dis 1993;17 suppl 1:32-6   DOI   ScienceOn
2 Foy HM, Kenney GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979;139:681-7   DOI   ScienceOn
3 Park HY, Woo CW, Choung JT, Son CS, Tockgo YC. Trend of the Mycoplasma pneumoniae : during recent 9 years period. Pediatr Allergy Respir Dis 1995;5:49-59
4 Hong JY, Nah SY, Nam SG, Choi EH, Park JY, Lee HJ. Occurrence of Mycoplasma pneumoniae pneumonia m Seoul, Korea, from 1986 to 1995. J Korean Pediatr Soc 1997:40:607-13
5 Lind K, Bentzon MW. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect 1991;107:189-99   DOI   ScienceOn
6 Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1986:5:71-85   DOI
7 Evatt BC, Dowdle WR, Johnson M. Epidemic Mycoplasma pneumoniae pneumonia. N Engl J Med 1971;285:374-8   DOI   ScienceOn
8 Foy HM, Kenny GE, Cooney MK, Allan ID, van Belle G. Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae. J Infect Dis 1983;147:967-73   DOI   ScienceOn
9 Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 1997;13:581-6   DOI   ScienceOn
10 Kang KS, Woo H. Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children: southern central Korea, from 1989 to 2002. J Korean Pediatr Soc 2003; 46:474-9
11 Hosker HS, Tam JS, Chain CH, Lai CK. Mycoplasma pneumoniae infection in Hong Kong - Clinical and Epidemiological Features during and Epidemic. Respiration 1993;60:237 -40   DOI   ScienceOn
12 Ferrari M, Poli A, Olivieri M, Verlato G, Tardivo S, Nicolis M, et al. Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults. Infection 2002;30:203-7   DOI   ScienceOn
13 Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003;9:263-7   DOI   ScienceOn
14 Kwon HO, Lee JH. Epidemic outbreak of Mycoplasma pneumoniae pneumonia in Korea, 2003. Proceedings of the 54th Annual Fall Meeting of Korean Pediatric Society; 2004 Oct 22-24; Seoul. Seoul: Korean Pediatric Society, 2004:294
15 Gencay M, Rudiger JJ, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001;163:1097-100   DOI
16 Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 1994; 149:1348-53   DOI   ScienceOn
17 Ghosh K, Clements GB. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986-1991. J Infect 1992;25: 221-7   DOI   ScienceOn
18 Srifuengfung S, Techachaiwiwat W, Dhiraputra C. Serological study of Mycoplasma pneumoniae infections. J Med Assoc Thai 2004;87:935-8
19 Brunner H. Mycoplasma pneumoniae infection. Isr J Med Sci 1981;17:516-23
20 Ito I, Ishida T, Osawa M, Arita M, Hashimoto T, Hongo T, et al. Cultural verified Mycoplasma pneumoniae pneumoma m Japan: a long-term observation from 1979-99. Epidemiol Infect 2001;27:365-7
21 Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, Friedman MG, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003;167:406-10   DOI   ScienceOn
22 Esposito S, Blasi F, Arosio C, Fioravanti L, Fagetti L, Droghetti R, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6   DOI   ScienceOn
23 Leland DS, Barth KA, Cunningham EB. Comparison of the Seradyn Color Vue passive agglutination test and complement fixation for detection of Mycoplasma pneumoniae antibodies. J Clin Microb 1993;31:1013-5
24 Fernald GW, Collier AM, Clyde WA. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 1975;55:327-35
25 Cunningham AF, Johnston SL, julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbation in children. Eur Respir J 1998;11:345-9   DOI   ScienceOn
26 Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma : an update. Clin Infect Dis 1996;23: 671-82   DOI   ScienceOn
27 Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol 1998;81:339-44   DOI   ScienceOn
28 Kraft M, Cassell GH, Henson JE, Watson H, Williamson J. Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998;158:998-1001   DOI   ScienceOn
29 Ieven M, Ursi D, Van Bever H, Quint W, Neisters HGM, Goossens H. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis 1996;173:1445-52   DOI   ScienceOn
30 Rastawicki W, Kaluzewski S, Jagielski M. Occurrence of serologically verified Mycoplasma pneumoniae infections m Poland in 1970-1995. Eur J Epidemiol 1998;14:37-40
31 Layani-rnilon MP, Gras I, Valette M, Luciani J, Stagnara J, Ayrnard M, et al. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, During five successive winter periods. J Clin Microbiol 1999;37:1721-6
32 Moule JH, Caul EO, Wreghitt TG. The specific IgM response to Mycoplasma pneumoniae infection: interpretation and application to early diagnosis. Epidemiol Infect 1987;99: 685-92   DOI   ScienceOn
33 Sakurai N, Nagayama Y, Honda A, Makuta M, Yamamoto K, Kojima S. Mycoplasma pneumoniae and other pathogens in the aetiology of lower respiratory tract infections among Japanese children. J Infect 1988;16:253-61   DOI   ScienceOn
34 Barker CE, Sillis M, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detection Mycoplasma pneumonae antibody: comparison with \mu -capture ELISA and indirect immunofluorescence. J Clin Pathol 1990;43:163-5   DOI   PUBMED
35 Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma. Thorax 1998;53:254-9   DOI   ScienceOn
36 Biscardi S, Lorrot M, Marc E, Moulin F, BoutonnatFaucher B, Helibronner C, et 31. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004;38:1341-6   DOI   ScienceOn